LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 45.61 | 770.25 | 5337 | 5813 | 0.9181 | 0.9423 | MN20160304_L02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 45.61 | 770.25 | 5957 | 5813 | 1.0248 | 1.0169 | MN20160304_L02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 47.83 | 770.25 | 5754 | 6223 | 0.9246 | 0.9486 | MN20160304_L02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 47.83 | 770.25 | 6357 | 6223 | 1.0215 | 1.0141 | MN20160304_L02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 50.05 | 770.25 | 6211 | 6629 | 0.9369 | 0.9584 | MN20160304_L02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 50.05 | 770.25 | 6699 | 6629 | 1.0105 | 1.0067 | MN20160304_L02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 52.27 | 770.25 | 6616 | 7058 | 0.9373 | 0.9599 | MN20160304_L02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 52.27 | 770.25 | 7184 | 7058 | 1.0177 | 1.0110 | MN20160304_L02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 54.49 | 770.25 | 7078 | 7555 | 0.9368 | 0.9608 | MN20160304_L02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 54.49 | 770.25 | 7626 | 7555 | 1.0093 | 1.0056 | MN20160304_L02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 56.71 | 770.25 | 7551 | 8001 | 0.9437 | 0.9660 | MN20160304_L02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 56.71 | 770.25 | 8131 | 8001 | 1.0162 | 1.0095 | MN20160304_L02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 58.94 | 770.25 | 7944 | 8444 | 0.9407 | 0.9650 | MN20160304_L02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 58.94 | 770.25 | 8484 | 8444 | 1.0047 | 1.0027 | MN20160304_L02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 61.16 | 770.25 | 8338 | 8892 | 0.9377 | 0.9639 | MN20160304_L02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 61.16 | 770.25 | 8763 | 8892 | 0.9855 | 0.9917 | MN20160304_L02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 63.39 | 770.25 | 8768 | 9326 | 0.9402 | 0.9660 | MN20160304_L02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 63.39 | 770.25 | 9042 | 9326 | 0.9695 | 0.9829 | MN20160304_L02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 65.61 | 770.25 | 9161 | 9736 | 0.9409 | 0.9670 | MN20160304_L02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 65.61 | 770.25 | 9392 | 9736 | 0.9647 | 0.9804 | MN20160304_L02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 67.83 | 770.25 | 9608 | 10078 | 0.9533 | 0.9744 | MN20160304_L02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 67.83 | 770.25 | 9630 | 10078 | 0.9555 | 0.9756 | MN20160304_L02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 70.05 | 770.25 | 9931 | 10413 | 0.9537 | 0.9749 | MN20160304_L02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 70.05 | 770.25 | 9956 | 10413 | 0.9561 | 0.9762 | MN20160304_L02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 72.27 | 770.25 | 10294 | 10730 | 0.9593 | 0.9783 | MN20160304_L02 | F15 |